Integrated Endoscopy said today it tapped Brad Sharp as its new prez & CEO, as well as joining the company’s board. The company said it is making the move with Sharp in preparation of the launch of its Nevis single-use arthroscope, which is slated for early 2017. The company said it also named Rob Cripe […]
RoundTable Healthcare Partners said today it sold its ophthalmic surgical device subsidiary Beaver-Visitec International Holdings to private investment firm TPG Capital for an undisclosed amount. Waltham, Mass.-based BVI produces Beaver blades, Visitec cannulae and instruments, Merocel and Weck-Cel ophthalmic fluid management products and Wet-Field Eraser electrosurgery products, and operates 2 manufacturing plants with locations in […]
RoundTable Healthcare Partners said this week that it closed the $140.3 million buyout of Symmetry Surgical, the legacy business formed after Symmetry Medical sold its orthopedics OEM operation to Tecomet in 2014. Nashville-based Symmetry Surgical makes reusable, reposable and single-use surgical instrumentation and specialty devices. The Lake Forest, Ill.-based private equity shop said it plans to leave president & CEO […]
RoundTable Healthcare Partners said it paid $140.3 million for Symmetry Surgical, the legacy business formed after Symmetry Medical sold its orthopedics OEM operation to Tecomet in 2014. Nashville-based Symmetry Surgical makes reusable, reposable and single-use surgical instrumentation and specialty devices. RoundTable said it expects to close the deal late in the 2nd quarter or early in the […]
Arlington Capital said today that it acquired medical device maker Avalign Technologies in a sale financed by CIT Healthcare. Forest, Ill.-based Avalign manufactures implants, specialty instrumentation, cutting tools, cases and trays for the orthopedic medical device and specialty surgical markets. “We are extremely pleased to be partnering with Arlington Capital. Avalign is committed to improving […]
Boston Scientific (NYSE:BSX) employees could see their annual bonus payments shrink or grow based on the device maker’s adjusted earnings per share and global sales by the end of the year, thanks to a new performance incentive plan for 2012.
The Natick, Mass.-based med-tech titan reconfigured its employee reward system, tying the total potential payout for all regions and division into a single pool, the value of which fluctuates along with the company’s performance in 2012.
The souring economy put a dent in the white-hot leveraged buyout market for the med-tech industry, a panel of fund managers said yesterday at the AdvaMed 2011 conference in Washington.
The European banks crisis, an uncertain regulatory environment in the U.S. and a looming new tax on medical devices all have mixed into a toxic stew that’s choking the LBO market, which had surged back since the economic slump in 2009.